The role of epigenetic modifications in drug resistance and treatment of breast cancer
Abstract Background Breast cancer is defined as a biological and molecular heterogeneous disorder that originates from breast cells. Genetic predisposition is the most important factor giving rise to this malignancy. The most notable mutations in breast cancer occur in the BRCA1 and BRCA2 genes. Owi...
Main Authors: | Mohsen Karami Fath, Ali Azargoonjahromi, Arash Kiani, Fateme Jalalifar, Parisa Osati, Mahsa Akbari Oryani, Fateh Shakeri, Farhad Nasirzadeh, Behman Khalesi, Mohsen Nabi-Afjadi, Hamidreza Zalpoor, Maysam Mard-Soltani, Zahra Payandeh |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-06-01
|
Series: | Cellular & Molecular Biology Letters |
Subjects: | |
Online Access: | https://doi.org/10.1186/s11658-022-00344-6 |
Similar Items
-
Exosome application in treatment and diagnosis of B-cell disorders: leukemias, multiple sclerosis, and arthritis rheumatoid
by: Mohsen Karami Fath, et al.
Published: (2022-09-01) -
Anti-cancer peptide-based therapeutic strategies in solid tumors
by: Mohsen Karami Fath, et al.
Published: (2022-04-01) -
OprF and OprL Conjugate as Vaccine Candidates against Pseudomonas aeruginosa; an in Silico Study
by: Zahra Payandeh, et al.
Published: (2018-01-01) -
Current understanding of epigenetics role in melanoma treatment and resistance
by: Mohsen Karami Fath, et al.
Published: (2022-10-01) -
Lectins and lectibodies: potential promising antiviral agents
by: Mohsen Nabi-Afjadi, et al.
Published: (2022-05-01)